Development of a Rat Model by 3,4-benzopyrene Intra-pulmonary Injection and Evaluation of the Effect of Green Tea Drinking on P53 and Bcl-2 Expression in Lung Carcinoma
Overview
Affiliations
Background: A convenient animal model of primary lung cancer is compelling for investigation into the disease mechanisms and for development of therapeutic strategies. This study aims to develop a reproducible rat model for lung carcinoma by intra-pulmonary injection of 3,4-benzopyrene, and to evaluate the preventive effect of green tea on the formation of lung carcinoma.
Methods: Sprague-Dawley rats of the same ages were randomly assigned into three groups treated differently. Rats in group one were given green tea in drinking water (tea concentration: 1.2%; tea polyphenols in the tea solution: 0.3%); rats in the groups two and three were given blank drinking water. Rats in the groups one and two were injected intra-pulmonarily with 3,4-benzopyrene dissolved in corn oil (2 mg/0.2 mL/injection, fortnightly, 4 times in all); rats in the group three were injected with the vehicle corn oil as the control for injection. All the rats were sacrificed one year after the first intra-pulmonary injection. Tumors developed in rats and lung tissues were collected for carcinoma diagnosis and for p53 and bcl-2 expression.
Results: Intra-pulmonary injection of 3,4-benzopyrene steady induced lung carcinoma at a success rate of 75%. Administration with green tea drinking significantly reduced the incidence of lung carcinoma to 30%. Green tea up-regulated p53 expression in lung carcinoma, but significantly down-regulated bcl-2 expression.
Conclusions: Intra-pulmonary injection of 3,4-benzopyrene can steady induce lung carcinoma in rats, and green tea has preventive effect against lung cancer possibly by regulating expression of some critical genes such as p53 and bcl-2.
Jiang Z, Li J, Huang G, Yan L, Ma J Heliyon. 2024; 10(12):e33137.
PMID: 39022033 PMC: 11252741. DOI: 10.1016/j.heliyon.2024.e33137.
Koriem K, Abdeen A Lab Anim Res. 2023; 39(1):28.
PMID: 37950334 PMC: 10636980. DOI: 10.1186/s42826-023-00179-y.
Pradhan B, Bhuyan P, Ki J Mar Drugs. 2023; 21(5).
PMID: 37233494 PMC: 10223415. DOI: 10.3390/md21050300.
Gu Q, Chen F, Chen N, Wang J, Li Z, Deng X Int J Mol Med. 2021; 48(6).
PMID: 34676878 PMC: 8559702. DOI: 10.3892/ijmm.2021.5053.
Gu Q, Hu C, Chen N, Qu J Int J Clin Exp Pathol. 2020; 11(8):3934-3942.
PMID: 31949781 PMC: 6962791.